Fig. 1 · Structure
Documents & Downloads
PDS-MMAE
Modified MMAE
PDS-MMAE is a modified form of MMAE, designed for use in the development of neurotensin receptor binding conjugates. This compound enhances the selective delivery of cytotoxic agents, facilitating targeted therapy in oncology research. PDS-MMAE is valuable in investigations aimed at elucidating the role of neurotensin receptors in cancer biology and therapeutic applications.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1613113-44-2 |
| Applications | Modified MMAE |
| Formula | C47H74N6O9S2 |
| Molecular Weight | 931.26 |
| SMILES | C[C@@H](C(N[C@H](C)[C@H](C1=CC=CC=C1)O)=O)[C@H]([C@@](CCC2)([H])N2C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@H](C(C)C)N(C)C(OCCSSC3=CC=CC=N3)=O)=O)=O)=O)OC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.